Strategic clarity: The new currency in life science
In an industry shaped by rapid regulatory changes and global competition, leading life science ...
Category: News (5)
Strategic considerations for a successful 510k Submission 3
In the third part of our article series on the FDA’s new “radical transparency” initiative, we ...
Navigate the potential impact of radical transparency
In the second part of our article series on the FDA’s new “radical transparency” initiative, we ...
SCRO is now Aurevia
We are happy to announce that Scandinavian CRO (SCRO) is now operating under the name of Aurevia, ...
QAdvis is now Aurevia – Expanding our capabilities together
QAdvis is now Aurevia – expanding our capabilities together We are happy to announce that QAdvis is ...
Merging expertise: Clinical research and regulatory affairs
In January, Aurevia was established from the merger of five European companies within clinical ...
Ulrika Hammarström appointed new Head of CRO
Last year, Aurevia (formerly LabQuality) acquired Scandinavian CRO. Recently, Ulrika Hammarström, ...
The FDA is being restructured and the world is holding its breath
For nearly 30 years, the U.S. Food and Drug Administration has played a pivotal role in shaping the ...
Health technology assessment regulation
The Health Technology Assessment Regulation (HTAR), officially known as Regulation (EU) 2021/2282, ...